- Build a leading global group in the market for medical devices
- Strengthen our offering and our expertise
- Surpass market growth in selected segments
- Combine organic growth with acquisitions
- Continuously increase the proportion of our own products and services.
- Achieve long term annual growth in excess of 10 percent for the Group.
- Achieve long term profitability of an operating margin in excess of 13 percent.
- Achieve share of own product in excess of 13 percent.
- Net sales including including acquisitions of 1 000 MSEK
Definitions of key performance indicators
|Total assets||The value of all assets||Relevant for enabling stakeholders to easily follow changes in consolidated total assets|
|Yield||Dividend in relation to share price at balance sheet date||Relevant for providing a measure of the return generated by an equity investment in the form of dividends|
|Equity per share||Equity attributable to shareholders parent company’s divided by the number of outstanding shares at the end of the period||A measure of the amount of equity that belongs to the shareholders of the parent company|
|Risk-bearing capital||The total of the reported amount of equity, any minority interests and deferred tax liability||Relevant from a credit point of view, and is one component showing the ability to sustain losses|
|Share of risk-bearing capital||Risk-bearing capital as a percentage of total assets||Relevant from a credit point of view, shows the ability to sustain losses|
|Liquidity reserve||Cash and cash equivalents and undrawn bank overdraft facilities at the end of the period||Relevant for assessing the ability to finance future operations as well as variations in the company’s cash flow|
|Net debt||Interest-bearing liabilities and interest-bearing provisions (provisions for pensions) less for cash and cash equivalents||Relevant for assessing the total interest-bearing debt burden|
|Net sales adjusted for currency translation||Changes in net sales adjusted for changes in exchange rates attributable to translation of subsidiaries compared with the same period last year||Relevant for assessing the change in net sales compared with previous year|
|Operating capital||Total assets as stated in the balance sheet less non-interest-bearing liabilities, non-interest-bearing provisions, interest-bearing non-current receivables and cash and cash equivalents||Capital tied up in the business|
|Return on operating capital||Operating profit as a percentage of average operating capital||Relevant for assessing the return on capital tied up in the business|
|Earnings after tax per share||Profit for the period divided by the average number of shares||Relevant for enabling investors to assess the return on and the valuation of the shares|
|Operating profit (EBIT)||Operating profit before tax and financial items||Relevant as a measure of the results of the company’s operating activities|
|Operating margin (EBIT %)||Operating profit as a percentage of net sales||Relevant for assessing the proportion of revenue retained as profit from operating activities. Can also be used for comparisons between companies|
|Operating profit before depreciation and amortization (EBITDA)||Operating profit before scheduled depreciation and amortization, and impairment||Relevant as a measure of the business’s ability to generate cash flow before tied up working capital and financial activities|
|EBITDA margin||Operating profit before scheduled depreciation and amortization, and impairment, as a percentage of net sales for the year||Relevant as a measure of the business’s ability to generate cash flow in relation to net sales|
|Debt/equity ratio||Net debt divided by equity||Relevant for assessing the capital structure, the ratio between equity and debt|
|Equity ratio||Equity including any minority interests as a percentage of total assets||Relevant as a measure of self-financing, as it shows the proportion of assets financed by equity|